跳至主要内容
临床试验/NCT00797394
NCT00797394已完成2 期

Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto

innoVactiv Inc.8 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2008年11月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
110
试验地点
8
主要终点
Absolute and relative (%) change in IPSS between baseline and end of study

研究概览

简要总结

The purpose of this study is to determine if the combination of 2007RD01, a natural extract, and saw palmetto lipidic extract, is more effective at treating lower urinary tract symptoms associated with benign prostatic hyperplasia than saw palmetto lipidic extract alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patient must be an adult man aged between 50 and 75
  • Patient must have Benign Prostatic Hyperplasia symptoms

排除标准

  • Patient has a malfunction of the urinary tract, is suffering from acute urinary retention, or is suffering from prostate cancer or urinary tract infection
  • Patient has been subjected to surgery of the prostate, bladder or urethra
  • Patient has taken a 5-alpha-reductase inhibitor in the 6-month period preceding screening
  • Patient has taken an alpha-blocker in the 2-week period preceding screening

结局指标

主要结局

Absolute and relative (%) change in IPSS between baseline and end of study

时间窗: 90 days ±7 days

次要结局

  • Absolute and relative (%) change in IPSS between baseline and day 30 of follow-up(30 days ±7 days)
  • Absolute and relative (%) change in peak urinary flow between baseline and after 30 or 90 days of follow-up(30 days ±7 days , 90 days ±7 days)
  • Absolute and relative (%) change in post-void residual volume between baseline and after 30 or 90 days of follow-up(30 days ±7 days , 90 days ±7 days)
  • Change in health related quality of life between baseline and after 30 or 90 days of follow-up(30 days ±7 days , 90 days ±7 days)
  • Change in sexual function between baseline and after 30 or 90 days of follow-up(30 days ±7 days , 90 days ±7 days)

研究者

申办方类型
Industry

研究点 (8)

Loading locations...

相似试验